Press Release: Commission takes measures to help rare disease patients

Author (Corporate)
Series Title
Series Details IP/00/413 (27.4.00)
Publication Date 27/04/2000

The European Commission has adopted a regulation laying down rules for implementing the European Parliament and Council Regulation 141/2000, on Orphan Medicinal Products, which opens up new treatment opportunities for patients with rare, or 'orphan' diseases. These rules will encourage the pharmaceutical industry to invest in developing treatments for rare and/or 'uneconomic' diseases, which affect fewer than 5 patients in every 10,000 of the EU population.
Source Link http://europa.eu/rapid/pressReleasesAction.do?reference=IP/00/413&format=HTML&rapid=0&language=EN&guiLanguage=en
Related Links
http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=en&type_doc=Regulation&an_doc=2000&nu_doc=141 http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=en&type_doc=Regulation&an_doc=2000&nu_doc=141
http://pharmacos.eudra.org http://pharmacos.eudra.org
Website: European Medicines Agency http://www.ema.europa.eu/ema/index.jsp
Subject Categories ,
Countries / Regions